Disruptions to this tightly orchestrated glucoregulatory system can lead to hyperglycaemia and the metabolic disorder of diabetes, which include decreased glucose usage, increased glucose production, a failure to secrete sufficient quantities of insulin, and insulin resistance [2]. This evidence concerns the gene INS and metabolic disease.